Your session is about to expire
← Back to Search
Deep Brain Stimulation for Spasmodic Dysphonia
Study Summary
This trial will enroll people with Adductor Laryngeal Dystonia (ADLD) to study the efficacy of Deep Brain Stimulation (DBS) in treating the condition. DBS is a neurosurgical procedure used to treat tremors and dystonia. Before surgery, participants will undergo specialized testing to study the movement of the vocal cords, as well as functional MRI. In the operating room, researchers will examine brain waves to better understand how faulty brain firing patterns lead to dystonia. After surgery, participants will repeat speech testing and vocal cord imaging as well as MRI.
- Spasmodic Dysphonia
- Adductor Spastic Dysphonia
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2018 Phase 2 trial • 53 Patients • NCT01221948Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Who is allowed to join in this medical experiment?
"Eligibility for this clinical trial requires adductor spastic dysphonia of dystonia and an age range between 18 to 70. This research study is striving to recruit 12 participants in total."
Are individuals aged 55 or above able to partake in this research?
"This medical trial has an age criteria of 18 to 70 years old, and is thus open for enrolment by those that meet this requirement."
Are there any unfilled positions for participants in this experiment?
"At present, clinicaltrials.gov reports that this trial is not recruiting patients, as the post dated 9th September 2022 has been last updated on 16th August 2022. Nevertheless, 48 other trials are currently in search of participants at this time."
What are the primary aims of this medical experiment?
"The primary aim of this experiment, tested before and after surgery over a 6-month period, is to measure changes in acoustic voice recordings. Secondary metrics include fluctuations on Neuropsychological testing Trails B (mental flexibility), Trails A (psychomotor speed) and the Voice Handicap Index - an indicator ranging from 0 to 120 which determines patients' vocal handicap severity."
Share this study with friends
Copy Link
Messenger